Search
forResearch 10 of 1000+
- Extracellular vesicles derived from embryonic day 13 fetal mouse dermal fibroblasts exhibit potential antifibrotic activity
- Pathological Skin Scarring: From Mechanism to Targeted Local Therapy
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis
- Identification of immune microenvironment changes, immune-related pathways and genes in male androgenetic alopecia
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Prediction and Demonstration of Retinoic Acid Receptor Agonist Ch55 as an Antifibrotic Agent in the Dermis
- 461: THE PROFIBROGENIC ROLE OF NEUTROPHIL EXTRACELLULAR TRAPS IN STENOTIC CROHN'S DISEASE: A NEW ANTIFIBROTIC TARGET?
- A histological study of the effect of panax ginseng versus finasteride on induced benign prostatic hyperplasia in rats with potentiality of spontaneous recovery
- Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia
Community 3 of 246
- Topical caffeine as an adjunct treatment. I think this should be considered.
- Taurine supplements work for hair growth?
- Reducing Fibrosis in Hair Loss: Topical Pirfenidone
Learn
— no results
Try a deeper search in learn →